{
    "clinical_study": {
        "@rank": "119235", 
        "arm_group": {
            "arm_group_label": "Patients receiving chronic hemodialysis", 
            "description": "Dialysis patients chewing chitosan-containing gum"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the pilot study is to determine the impact of short-term administration of\n      chitosan-containing chewing gum on phosphate levels in patients with elevated serum\n      phosphate levels."
        }, 
        "brief_title": "Chitosan Chewing Gum Study in Dialysis Patients", 
        "completion_date": {
            "#text": "January 2011", 
            "@type": "Actual"
        }, 
        "condition": "End Stage Renal Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "The impact of using salivary phosphate binders in ESRD patients is not fully known. The\n      purpose of the pilot study is to determine the impact of short-term administration of\n      chitosan-containing chewing gum on phosphate levels in patients with elevated serum\n      phosphate levels."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18-64 years old\n\n          -  ESRD receiving hemodialysis\n\n          -  serum phosphate > 6.0 mg/dL\n\n        Exclusion Criteria:\n\n          -  Unable to sign consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "64 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Outpatient hemodialysis facility"
            }
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01770470", 
            "org_study_id": "HP-00045129"
        }, 
        "intervention": {
            "arm_group_label": "Patients receiving chronic hemodialysis", 
            "description": "The product chitosan is contained in a chewing gum formulation", 
            "intervention_name": "Chitosan", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Chitosan"
        }, 
        "intervention_browse": {
            "mesh_term": "Chitosan"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "serum phosphate", 
            "chitosan", 
            "kidney disease", 
            "salivary phosphate"
        ], 
        "lastchanged_date": "January 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21201"
                }, 
                "name": "University of Maryland"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Pilot Study of Dietary Chitosan Chewing Gum in Dialysis Patients", 
        "overall_official": {
            "affiliation": "University of Maryland, Baltimore County", 
            "last_name": "Thomas Dowling, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Serum phosphate will be drawn 3 times per week over 2 weeks (during gum therapy), then once at 4 weeks and once at 6 weeks.", 
            "measure": "Serum phosphate", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01770470"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Maryland", 
            "investigator_full_name": "Thomas Dowling", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Salivary phosphate will be assessed 3 times per week over 2 weeks (during gum therapy), then once at 4 weeks and once at 6 weeks.", 
            "measure": "Salivary phosphate levels", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "source": "University of Maryland", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Maryland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2010", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}